Publication | Closed Access

In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders

Molecular PharmacologyPsychoactive DrugPsychiatric DisordersPsychiatryMedicineDepressionAnimal ModelsNeuropharmacologyPsychopharmacologySocial SciencesExperimental PharmacologyNeuroscienceBiological PsychiatryMood DisordersPharmacologyPsychopathologyVivo Pharmacological Characterization